Clinical trials in Maribor – page 2

Research focusing on breakthrough treatments for Multiple Sclerosis and neurodegenerative conditions, including evaluations of novel therapies like remibrutinib and ocrelizumab. Studies are examining treatment effectiveness for patients with various forms of MS.

• Relapsing Multiple Sclerosis (RMS)
• Early Alzheimer's Disease
• Refractory Focal Onset Epilepsy

Innovative trials exploring cognitive improvement and disease progression reduction.

Comprehensive studies evaluating treatments for Sjögren's Syndrome and other autoimmune disorders, with particular focus on systemic manifestations and long-term safety profiles.

• IgA Nephropathy
• Hidradenitis Suppurativa
• Crohn's Disease

Trials aimed at developing targeted therapies for moderate to severe disease manifestations.

Advanced clinical investigations in Non-Small Cell Lung Cancer and gynecological cancers, evaluating novel combination therapies and maintenance treatments.

• Advanced Endometrial Cancer
• Multiple Myeloma
• PD-L1 High NSCLC

Focus on immunotherapy combinations and targeted treatment approaches.

Studies addressing acute medical conditions including cardiogenic shock and severe respiratory infections, with emphasis on improving patient outcomes.

• Traumatic Injury
• Community-Acquired Pneumonia
• Acute Myocardial Infarction

Research aimed at reducing mortality and improving treatment protocols in critical care settings.